Diabetes-Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
The researchers reviewed the clinical and imaging features of diabetes-associated cognitive impairment and the mechanisms linking diabetes to neurodegeneration. The article discusses emerging therapeutic strategies, including GLP-1 receptor agonists and SGLT2 inhibitors, and their potential neuroprotective effects.
What to check after reading
This is a review of diabetes-associated cognitive impairment, exploring the potential role of GLP-1 receptor agonists in cognitive protection.
Source
Calendar dates show when a case was added or scheduled. For event dates, check the original source.